Browsing Category
Healthcare Industry News
2470 posts
Is Labcorp’s partnership with Roche the turning point for AI in cancer diagnostics?
Labcorp and Roche launch a digital pathology partnership to prepare diagnostics for AI—explore the market impact, stock sentiment, and industry risks.
CFO relocation signals Smith & Nephew’s U.S. pivot — but will investors buy the story?
Smith & Nephew shifts CFO base to the U.S. as it doubles down on revenue leadership and margins. Find out what it means for investors and growth strategy.
Can Ambac’s $250m ArmadaCare bet turn it into a specialty insurance powerhouse?
Ambac (NYSE: AMBC) exits guarantees with $420M Oaktree deal and acquires ArmadaCare for $250M, betting on specialty health insurance for growth.
Can Heather Hunter’s promotion to COO help Rockwell Medical win back investor confidence?
Rockwell Medical promotes Heather Hunter to COO as it seeks efficiency gains, investor confidence, and dialysis sector growth. Read the full analysis now.
GlucoTrack stock alert: Why are shareholders planning to sell 20 million shares of GCTK?
GlucoTrack (NASDAQ: GCTK) shareholders plan to sell 20M shares. Discover what this means for investors, dilution risks, and biotech stock sentiment.
Uscom Limited (ASX: UCM) bets on Singapore lifeline: What the AXO Medtech deal means for shareholders now
Uscom Limited (ASX: UCM) will sell its business to Singapore’s AXO Medtech for AUD 2.59M. Find out how this deal impacts investors and the company’s future.
Melinda Gates and ICONIQ Impact launch $100m women’s health fund set to transform global philanthropy
ICONIQ Impact’s $100M Women’s Health Co-Lab with Co-Impact targets maternal care, reproductive rights, and safety. See how philanthropy is driving change.
First Health Advisory chosen by American Hospital Association to boost hospital resilience against ransomware attacks
First Health Advisory named Preferred Cybersecurity Provider by the AHA, strengthening hospital resilience against ransomware and cyber risks.
Johnson & Johnson wins FDA approval for Tremfya in pediatric psoriasis and psoriatic arthritis
Johnson & Johnson wins FDA approval for Tremfya in pediatric psoriasis and psoriatic arthritis, extending its immunology lead and boosting growth prospects.
Axon Therapies bags $32m to push heart failure trials—can this MedTech deliver where drugs failed?
Axon Therapies raises $32M to advance implant-free heart failure therapy. Learn how its splanchnic ablation trials could reshape cardiology.